Covered recipient · General Payments record
AMANDA NICOLE VANSCOY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024–2025
$231.57
- Reported across 10 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): (records>=3 OR total>=100) AND records>=2 AND NPI identity (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $209.65 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $58.43 | 2 |
| GlaxoSmithKline, LLC. | $52.85 | 2 |
| Exact Sciences Corporation | $22.42 | 1 |
| Acerta Pharma LLC | $22.03 | 1 |
| Lilly USA, LLC | $20.42 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.28 | 1 |
| ABBVIE INC. | $15.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.22 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203918306 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.03 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207257144 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.28 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225871321 | CMS |
| Exact Sciences Corporation | $22.42 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235487743 | CMS |
| GlaxoSmithKline, LLC. | $29.89 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191423316 | CMS |
| GlaxoSmithKline, LLC. | $22.96 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190843155 | CMS |
| Lilly USA, LLC | $20.42 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186947629 | CMS |
| Novo Nordisk Inc | $26.45 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188638964 | CMS |
| Novo Nordisk Inc | $31.98 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189000523 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.